KELLY TOLER: Open Payments
NPI 1083608244 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 91 payments from 14 companies in 2025. Trend: 2023 $1,143 · 2024 $1,559 · 2025 $1,833
Food & beverage: $1,738Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $411 |
| ABBVIE INC. | 20 | $325 |
| GENZYME CORPORATION | 8 | $293 |
| Regeneron Healthcare Solutions, Inc. | 9 | $244 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $90 |
| Incyte Corporation | 5 | $86 |
| PFIZER INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $45 |
| Organogenesis Inc. | 1 | $41 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, RINVOQ, Sotyktu, COSENTYX, OPZELURA, TALTZ.
Industry payments across GA — which companies pay providers there.
